In eight years, the global cell therapy market is set to grow from USD 6.86 billion in 2025 to USD 33.93 billion. 

This expected growth, at a CAGR of 22.12%, is as a result of rapid advances in stem cell research, according to Straits Research. 

The market intelligence company highlights that a continuing availability of grants from government and corporate funding sources to support clinical trials into cell therapy treatments is driving the market.  

Straits Research said, “Rapid advances in stem cell research offer the potential to address unmet disease management requirements in the pharmaceutical, biotech, and medical industries… Furthermore, the rising desire for personalised treatment and public knowledge of the benefits of cell therapy is expected to provide new business opportunities in the field.”  

Statistics suggest that North America is the most significant global cell therapy market shareholder, with an estimated CAGR of 14.8% over the forecast period.